Whittier Trust Co. lowered its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 6.7% in the fourth quarter, Holdings Channel reports. The fund owned 12,575 shares of the financial services provider’s stock after selling 902 shares during the quarter. Whittier Trust Co.’s holdings in CME Group were worth $2,920,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in the stock. Raymond James Financial Inc. acquired a new position in CME Group during the 4th quarter worth approximately $871,063,000. Franklin Resources Inc. increased its holdings in shares of CME Group by 70.4% during the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after buying an additional 1,003,119 shares in the last quarter. Capital Wealth Planning LLC boosted its holdings in shares of CME Group by 69.2% during the 4th quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock valued at $565,671,000 after acquiring an additional 996,498 shares in the last quarter. Egerton Capital UK LLP bought a new stake in CME Group during the 4th quarter worth $223,967,000. Finally, Canoe Financial LP increased its holdings in CME Group by 698.0% in the 4th quarter. Canoe Financial LP now owns 544,219 shares of the financial services provider’s stock worth $126,384,000 after purchasing an additional 476,019 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Stock Performance
NASDAQ:CME opened at $263.35 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $267.91. The company has a fifty day moving average of $246.50 and a 200-day moving average of $234.07. The firm has a market capitalization of $94.90 billion, a P/E ratio of 27.23, a P/E/G ratio of 6.76 and a beta of 0.53.
CME Group declared that its Board of Directors has authorized a stock repurchase plan on Thursday, December 5th that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s management believes its shares are undervalued.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be issued a $1.25 dividend. The ex-dividend date is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.90%. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio is presently 51.71%.
Insider Buying and Selling at CME Group
In other CME Group news, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $260.00, for a total transaction of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares in the company, valued at approximately $5,686,980. The trade was a 31.37 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the sale, the chief operating officer now directly owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. This trade represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,076 shares of company stock valued at $6,871,496. Company insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on CME shares. Erste Group Bank raised CME Group to a “strong-buy” rating in a research note on Monday, March 17th. Morgan Stanley boosted their target price on shares of CME Group from $256.00 to $263.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 19th. Oppenheimer raised their price target on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a research note on Thursday, February 13th. Finally, Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $255.00 to $250.00 in a report on Monday, January 6th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $238.93.
Read Our Latest Stock Analysis on CME
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- EV Stocks and How to Profit from Them
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What Is WallStreetBets and What Stocks Are They Targeting?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.